PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

FiftyOne Capital, page-41

  1. 6,009 Posts.
    lightbulb Created with Sketch. 1153
    yeah, there will certainly be demand... i would expect when 51 went to the efforts of going to Germany for due diligence that they would have considered and discussed quantities potentially needed. Afterall, they've run financial models on revenues to be generated at # per injection etc, so they have the numbers they believe will be required.

    The only people as keen on PAR selling tonnes of product as us PAR holders are Bene themselves no doubt.

    Certainly multiple sites and countries would be wonderful for some diversification...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.